Android app on Google Play

Viropharma, Inc. (VPHM) Tops Q4 EPS by 7c; Guides FY Sales In-Line

February 27, 2013 7:33 AM EST Send to a Friend
Viropharma, Inc. (NASDAQ: VPHM) reported Q4 EPS of $0.10, $0.07 better than the analyst estimate of $0.03. Revenue for the quarter came in at $106.5 million versus the consensus estimate of $103.06 million.

Viropharma, Inc. sees FY2013 revenue of $450-475 million, versus the consensus of $460.07 million.

For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment